1. 'Progressive MS – macro views': The need for novel clinical trial paradigms to enable drug development for progressive MS. (October 2017) Authors: Zaratin, P; Comi, G; Leppert, D Other Names: Chataway Jeremy guest-editor.; Fox Robert guest-editor. Journal: Multiple sclerosis Issue: Volume 23:Number 12(2017) Page Start: 1649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advancing trial design in progressive multiple sclerosis. (October 2017) Authors: Miller, David H; Thompson, Alan J Other Names: Chataway Jeremy guest-editor.; Fox Robert guest-editor. Journal: Multiple sclerosis Issue: Volume 23:Number 12(2017) Page Start: 1571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Advancing trial design in progressive multiple sclerosis. (October 2017) Authors: Fox, Robert J; Chataway, Jeremy Other Names: Chataway Jeremy guest-editor.; Fox Robert guest-editor. Journal: Multiple sclerosis Issue: Volume 23:Number 12(2017) Page Start: 1573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical outcome measures for progressive MS trials. (October 2017) Authors: Ontaneda, Daniel; Cohen, Jeffrey A; Amato, Maria Pia Other Names: Chataway Jeremy guest-editor.; Fox Robert guest-editor. Journal: Multiple sclerosis Issue: Volume 23:Number 12(2017) Page Start: 1627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical trial design for progressive MS trials. (October 2017) Authors: Pardini, Matteo; Cutter, Gary; Sormani, Maria Pia Other Names: Chataway Jeremy guest-editor.; Fox Robert guest-editor. Journal: Multiple sclerosis Issue: Volume 23:Number 12(2017) Page Start: 1642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Fluid biomarker and electrophysiological outcome measures for progressive MS trials. (October 2017) Authors: Barro, Christian; Leocani, Letizia; Leppert, David; Comi, Giancarlo; Kappos, Ludwig; Kuhle, Jens Other Names: Chataway Jeremy guest-editor.; Fox Robert guest-editor. Journal: Multiple sclerosis Issue: Volume 23:Number 12(2017) Page Start: 1600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Imaging outcome measures for progressive multiple sclerosis trials. (October 2017) Authors: Moccia, Marcello; de Stefano, Nicola; Barkhof, Frederik Other Names: Chataway Jeremy guest-editor.; Fox Robert guest-editor. Journal: Multiple sclerosis Issue: Volume 23:Number 12(2017) Page Start: 1614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patient selection for trials. (October 2017) Authors: Wolinsky, Jerry S Other Names: Chataway Jeremy guest-editor.; Fox Robert guest-editor. Journal: Multiple sclerosis Issue: Volume 23:Number 12(2017) Page Start: 1636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Progressive MS trials: Lessons learned. (October 2017) Authors: Tur, Carmen; Montalban, Xavier Other Names: Chataway Jeremy guest-editor.; Fox Robert guest-editor. Journal: Multiple sclerosis Issue: Volume 23:Number 12(2017) Page Start: 1583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Targets of therapy in progressive MS. (October 2017) Authors: Lassmann, Hans Other Names: Chataway Jeremy guest-editor.; Fox Robert guest-editor. Journal: Multiple sclerosis Issue: Volume 23:Number 12(2017) Page Start: 1593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗